Verona Pharma Plc. (VRNA) NASDAQ
$15.21 (0.38) (-2.44%)
Market Cap: $807.85M
As of 04/24/24 03:59 PM EDT. Market closed.
Verona Pharma Plc. (VRNA)
NASDAQ
$15.21
(0.38) (-2.44%)
Market Cap: $807.85M
As of 04/24/24 03:59 PM EDT. Market closed.
Add to Portfolio
verona pharma is a clinical stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of respiratory diseases with significant unmet medical needs. we are currently focused on developing our novel lead therapeutic candidate in the treatment of chronic obstructive pulmonary fibrosis (copd) and cystic fibrosis (cf), and may expand our ... read more
COMPANY PROFILE
Sector
Manufacturing
Industry
Medicinal and Botanical Manufacturing
CEO
David Zaccardelli
Full Time Employees
40
Sector
Manufacturing
Industry
Medicinal and Botanical Manufacturing
CEO
David Zaccardelli
Full Time Employees
40
Address
Riverside, London, 3 More London Place, SE1 2RE.
PRICE CHART FOR VERONA PHARMA PLC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$15.71
Previous Close
$15.59
Days Range
$15.52 - $16
52 week range
$11.83 - $23.81
Volume
244,005
Avg. Volume (30 days)
426,138
Market Cap
$807.85M
Dividend Yield
-
P/E
(15.94)
Shares Outstanding
51,818,199
Open
$15.71
Previous Close
$15.59
Days Range
$15.52 - $16
52 week range
$11.83 - $23.81
Volume
244,005
Avg. Volume (30 days)
426,138
Market Cap
$807.85M
Dividend Yield
-
P/E
(15.94)
Shares Outstanding
51,818,199
FINANCIAL STATEMENTS FOR VERONA PHARMA PLC
LOADING...
INSIDER TRANSACTIONS FOR VERONA PHARMA PLC
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
ZACCARDELLI DAVID | President and CEO | Feb 01, 2024 | Option Exercise | $2.29 | 480,200 | 1,101,483 | 15,942,592 | Feb 05, 2024, 06:11 PM |
Rickard Kathleen A. | Chief Medical Officer | Feb 01, 2024 | Option Exercise | $2.29 | 72,768 | 166,915 | 2,767,872 | Feb 05, 2024, 06:11 PM |
Rickard Kathleen A. | Chief Medical Officer | Feb 05, 2024 | Sale | $2.22 | 36,248 | 80,503 | 2,731,624 | Feb 05, 2024, 06:11 PM |
Poll Claire | General Counsel | Feb 01, 2024 | Option Exercise | $2.29 | 103,408 | 237,197 | 1,740,079 | Feb 05, 2024, 06:10 PM |
Hahn Mark W | Chief Financial Officer | Feb 01, 2024 | Option Exercise | $2.29 | 480,664 | 1,102,547 | 15,031,576 | Feb 05, 2024, 06:09 PM |
Edwards Martin | Director | Nov 20, 2023 | Buy | $1.84 | 33,736 | 61,973 | 144,800 | Nov 22, 2023, 05:09 PM |
EBSWORTH DAVID R | Director | Nov 06, 2023 | Buy | $1.98 | 160,000 | 316,080 | 844,643 | Nov 08, 2023, 04:15 PM |
Rickard Kathleen A. | Chief Medical Officer | Nov 01, 2023 | Option Exercise | $1.74 | 173,136 | 301,915 | 2,899,392 | Nov 03, 2023, 08:11 PM |
Rickard Kathleen A. | Chief Medical Officer | Nov 03, 2023 | Sale | $1.92 | 58,752 | 112,804 | 2,840,640 | Nov 03, 2023, 08:11 PM |
Poll Claire | General Counsel | Nov 01, 2023 | Option Exercise | $1.74 | 173,904 | 303,254 | 1,843,487 | Nov 03, 2023, 08:09 PM |
ZACCARDELLI DAVID | President and CEO | Nov 01, 2023 | Option Exercise | $1.74 | 809,008 | 1,410,748 | 16,422,792 | Nov 03, 2023, 08:09 PM |
Hahn Mark W | Chief Financial Officer | Nov 01, 2023 | Option Exercise | $1.74 | 809,008 | 1,410,748 | 15,512,240 | Nov 03, 2023, 08:08 PM |
Rickard Kathleen A. | Chief Medical Officer | Aug 04, 2023 | Sale | $2.50 | 27,944 | 69,838 | 2,874,128 | Aug 07, 2023, 09:19 PM |
Rickard Kathleen A. | Chief Medical Officer | Aug 03, 2023 | Sale | $2.55 | 50,600 | 128,790 | 2,923,920 | Aug 07, 2023, 09:19 PM |
Rickard Kathleen A. | Chief Medical Officer | Aug 07, 2023 | Sale | $2.47 | 1,600 | 3,949 | 2,872,528 | Aug 07, 2023, 09:19 PM |
ZACCARDELLI DAVID | President and CEO | Aug 07, 2023 | Sale | $2.47 | 8,616 | 21,263 | 16,431,800 | Aug 07, 2023, 09:17 PM |
ZACCARDELLI DAVID | President and CEO | Aug 04, 2023 | Sale | $2.50 | 150,000 | 374,880 | 16,440,416 | Aug 07, 2023, 09:17 PM |
ZACCARDELLI DAVID | President and CEO | Aug 03, 2023 | Sale | $2.54 | 117,272 | 297,754 | 16,590,416 | Aug 07, 2023, 09:17 PM |
Hahn Mark W | Chief Financial Officer | Aug 04, 2023 | Sale | $2.50 | 150,000 | 374,880 | 15,529,864 | Aug 07, 2023, 09:17 PM |
Hahn Mark W | Chief Financial Officer | Aug 03, 2023 | Sale | $2.54 | 117,272 | 297,754 | 15,679,864 | Aug 07, 2023, 09:17 PM |
Hahn Mark W | Chief Financial Officer | Aug 07, 2023 | Sale | $2.47 | 8,616 | 21,263 | 15,521,248 | Aug 07, 2023, 09:17 PM |
Poll Claire | General Counsel | Aug 07, 2023 | Sale | $2.47 | 1,512 | 3,731 | 1,907,367 | Aug 07, 2023, 09:15 PM |
Poll Claire | General Counsel | Aug 04, 2023 | Sale | $2.50 | 26,352 | 65,859 | 1,908,879 | Aug 07, 2023, 09:15 PM |
Poll Claire | General Counsel | Aug 03, 2023 | Sale | $2.54 | 20,608 | 52,324 | 1,935,231 | Aug 07, 2023, 09:15 PM |
Hahn Mark W | Chief Financial Officer | Aug 01, 2023 | Sale | $2.68 | 105,944 | 283,824 | 15,870,840 | Aug 03, 2023, 08:31 PM |
Hahn Mark W | Chief Financial Officer | Aug 02, 2023 | Sale | $2.59 | 73,704 | 191,114 | 15,797,136 | Aug 03, 2023, 08:31 PM |
Poll Claire | General Counsel | Aug 02, 2023 | Sale | $2.59 | 12,944 | 33,564 | 1,955,839 | Aug 03, 2023, 08:30 PM |
Poll Claire | General Counsel | Aug 01, 2023 | Sale | $2.68 | 18,608 | 49,851 | 1,968,783 | Aug 03, 2023, 08:30 PM |
ZACCARDELLI DAVID | President and CEO | Aug 02, 2023 | Sale | $2.59 | 73,704 | 191,114 | 16,707,688 | Aug 03, 2023, 08:29 PM |
ZACCARDELLI DAVID | President and CEO | Aug 01, 2023 | Sale | $2.68 | 105,944 | 283,824 | 16,781,392 | Aug 03, 2023, 08:29 PM |
Rickard Kathleen A. | Chief Medical Officer | Aug 02, 2023 | Sale | $2.59 | 13,728 | 35,597 | 2,952,672 | Aug 03, 2023, 08:27 PM |
Rickard Kathleen A. | Chief Medical Officer | Aug 01, 2023 | Sale | $2.68 | 19,736 | 52,873 | 2,966,400 | Aug 03, 2023, 08:27 PM |
ORBIMED ADVISORS LLC | Director | May 15, 2023 | Sale | $20.08 | 359,713 | 7,222,484 | 4,123,091 | May 15, 2023, 06:07 PM |
ORBIMED ADVISORS LLC | Director | May 12, 2023 | Sale | $21.64 | 43,200 | 934,848 | 4,137,491 | May 15, 2023, 06:07 PM |
ORBIMED ADVISORS LLC | Director | May 11, 2023 | Sale | $22.26 | 80,000 | 1,780,800 | 4,180,691 | May 15, 2023, 06:07 PM |
Gupta Rishi | Director | May 15, 2023 | Sale | $20.08 | 359,713 | 7,222,484 | 4,123,091 | May 15, 2023, 06:06 PM |
Gupta Rishi | Director | May 12, 2023 | Sale | $21.64 | 43,200 | 934,848 | 4,137,491 | May 15, 2023, 06:06 PM |
Gupta Rishi | Director | May 11, 2023 | Sale | $22.26 | 80,000 | 1,780,800 | 4,180,691 | May 15, 2023, 06:06 PM |
Poll Claire | General Counsel | May 01, 2023 | Sale | $2.58 | 80,376 | 207,041 | 1,979,063 | May 03, 2023, 07:49 PM |
Rickard Kathleen A. | Chief Medical Officer | May 03, 2023 | Sale | $2.65 | 28,752 | 76,242 | 2,971,136 | May 03, 2023, 07:49 PM |
Rickard Kathleen A. | Chief Medical Officer | May 01, 2023 | Sale | $2.58 | 77,424 | 199,436 | 2,999,888 | May 03, 2023, 07:49 PM |
Hahn Mark W | Chief Financial Officer | May 01, 2023 | Sale | $2.58 | 455,528 | 1,173,395 | 15,976,784 | May 03, 2023, 07:48 PM |
ZACCARDELLI DAVID | President and CEO | May 01, 2023 | Sale | $2.58 | 455,536 | 1,173,415 | 16,887,336 | May 03, 2023, 07:46 PM |
Hahn Mark W | Chief Financial Officer | Feb 01, 2023 | Sale | $2.56 | 413,168 | 1,056,553 | 16,432,312 | Feb 03, 2023, 06:19 PM |
ZACCARDELLI DAVID | President and CEO | Feb 01, 2023 | Sale | $2.56 | 432,928 | 1,107,083 | 17,342,872 | Feb 03, 2023, 06:18 PM |
Rickard Kathleen A. | Chief Medical Officer | Feb 02, 2023 | Sale | $2.53 | 28,752 | 72,685 | 3,077,312 | Feb 03, 2023, 06:17 PM |
Rickard Kathleen A. | Chief Medical Officer | Feb 01, 2023 | Sale | $2.56 | 89,960 | 230,046 | 3,106,064 | Feb 03, 2023, 06:17 PM |
Poll Claire | General Counsel | Feb 01, 2023 | Sale | $2.59 | 152,000 | 394,273 | 774,256 | Feb 03, 2023, 06:15 PM |
Poll Claire | General Counsel | Dec 22, 2022 | Sale | $2.69 | 240,000 | 646,032 | 774,256 | Dec 27, 2022, 06:50 PM |
ORBIMED ADVISORS LLC | Director | Dec 23, 2022 | Sale | $22.84 | 2,170,368 | 49,576,607 | 35,294,568 | Dec 27, 2022, 05:38 PM |
ORBIMED ADVISORS LLC | Director | Dec 22, 2022 | Sale | $21.77 | 3,969,496 | 86,424,246 | 36,940,592 | Dec 27, 2022, 05:38 PM |
Gupta Rishi | Director | Dec 23, 2022 | Sale | $22.84 | 2,170,368 | 49,576,607 | 35,294,568 | Dec 27, 2022, 05:32 PM |
Gupta Rishi | Director | Dec 22, 2022 | Sale | $21.77 | 3,969,496 | 86,424,246 | 36,940,592 | Dec 27, 2022, 05:32 PM |
ZACCARDELLI DAVID | President and CEO | Dec 20, 2022 | Sale | $2.12 | 600,000 | 1,269,600 | 17,775,800 | Dec 21, 2022, 04:06 PM |
Hahn Mark W | Chief Financial Officer | Dec 20, 2022 | Sale | $2.12 | 600,000 | 1,269,060 | 16,845,480 | Dec 21, 2022, 04:05 PM |
ZACCARDELLI DAVID | President and CEO | Nov 01, 2022 | Option Exercise | $1.60 | 454,856 | 727,770 | 18,408,704 | Nov 03, 2022, 04:06 PM |
ZACCARDELLI DAVID | President and CEO | Nov 01, 2022 | Sale | $1.67 | 32,904 | 55,035 | 18,375,800 | Nov 03, 2022, 04:06 PM |
Rickard Kathleen A. | Chief Medical Officer | Nov 01, 2022 | Option Exercise | $1.60 | 56,264 | 90,022 | 3,119,776 | Nov 03, 2022, 04:05 PM |
Rickard Kathleen A. | Chief Medical Officer | Nov 01, 2022 | Sale | $1.64 | 28,752 | 47,125 | 3,091,024 | Nov 03, 2022, 04:05 PM |
Hahn Mark W | Chief Financial Officer | Nov 01, 2022 | Option Exercise | $1.60 | 454,856 | 727,770 | 17,458,640 | Nov 03, 2022, 04:05 PM |
Hahn Mark W | Chief Financial Officer | Nov 01, 2022 | Sale | $1.67 | 13,160 | 22,011 | 17,445,480 | Nov 03, 2022, 04:05 PM |
Access Industries Holdings LLC | 10% Owner | Aug 15, 2022 | Buy | $1.31 | 4,800,000 | 6,300,000 | 55,911,648 | Aug 17, 2022, 04:03 PM |
ZACCARDELLI DAVID | President and CEO | Aug 09, 2022 | Sale | $1.75 | 600,000 | 1,050,000 | 15,263,560 | Aug 11, 2022, 09:46 PM |
Hahn Mark W | Chief Financial Officer | Aug 09, 2022 | Sale | $1.75 | 600,000 | 1,050,000 | 14,313,496 | Aug 11, 2022, 09:45 PM |
ZACCARDELLI DAVID | President and CEO | Aug 01, 2022 | Option Exercise | $0.67 | 454,864 | 305,896 | 15,896,464 | Aug 03, 2022, 04:12 PM |
ZACCARDELLI DAVID | President and CEO | Aug 01, 2022 | Sale | $0.70 | 32,904 | 23,026 | 15,863,560 | Aug 03, 2022, 04:12 PM |
Rickard Kathleen A. | Chief Medical Officer | Aug 01, 2022 | Option Exercise | $0.67 | 56,432 | 37,951 | 2,404,792 | Aug 03, 2022, 04:11 PM |
Rickard Kathleen A. | Chief Medical Officer | Aug 02, 2022 | Sale | $0.70 | 28,752 | 20,216 | 2,376,040 | Aug 03, 2022, 04:11 PM |
Hahn Mark W | Chief Financial Officer | Aug 01, 2022 | Option Exercise | $0.67 | 454,856 | 305,891 | 14,926,664 | Aug 03, 2022, 04:10 PM |
Hahn Mark W | Chief Financial Officer | Aug 01, 2022 | Sale | $0.70 | 13,168 | 9,215 | 14,913,496 | Aug 03, 2022, 04:10 PM |
Poll Claire | General Counsel | Aug 01, 2022 | Option Exercise | $0.67 | 79,896 | 53,730 | 1,763,055 | Aug 03, 2022, 04:10 PM |
ZACCARDELLI DAVID | President and CEO | May 03, 2022 | Sale | $0.50 | 32,904 | 16,307 | 16,351,328 | May 05, 2022, 07:20 PM |
Rickard Kathleen A. | Chief Medical Officer | May 03, 2022 | Sale | $0.49 | 28,752 | 14,155 | 2,461,224 | May 05, 2022, 07:19 PM |
Hahn Mark W | Chief Financial Officer | May 03, 2022 | Sale | $0.50 | 12,512 | 6,201 | 15,381,520 | May 05, 2022, 07:18 PM |
Rickard Kathleen A. | Chief Medical Officer | May 01, 2022 | Option Exercise | $0.52 | 56,432 | 29,486 | 2,489,976 | May 03, 2022, 08:20 PM |
Poll Claire | General Counsel | May 01, 2022 | Option Exercise | $0.52 | 79,896 | 41,746 | 1,842,951 | May 03, 2022, 08:19 PM |
Hahn Mark W | Chief Financial Officer | May 01, 2022 | Option Exercise | $0.52 | 432,128 | 225,787 | 15,394,032 | May 03, 2022, 08:18 PM |
ZACCARDELLI DAVID | President and CEO | May 01, 2022 | Option Exercise | $0.52 | 454,864 | 237,666 | 16,384,232 | May 03, 2022, 08:17 PM |
Rickard Kathleen A. | Chief Medical Officer | Apr 11, 2022 | Sale | $0.54 | 59,720 | 32,100 | 2,546,408 | Apr 12, 2022, 04:05 PM |
Rickard Kathleen A. | Chief Medical Officer | Apr 08, 2022 | Sale | $0.59 | 112,800 | 66,383 | 2,606,128 | Apr 12, 2022, 04:05 PM |
Deschamps Lisa | Director | Feb 01, 2022 | Sale | $0.78 | 11,664 | 9,069 | 70,320 | Feb 03, 2022, 05:58 PM |
Rickard Kathleen A. | Chief Medical Officer | Feb 01, 2022 | Option Exercise | $0.78 | 63,560 | 49,335 | 2,718,928 | Feb 03, 2022, 05:57 PM |
ZACCARDELLI DAVID | President and CEO | Feb 01, 2022 | Option Exercise | $0.75 | 334,448 | 250,000 | 17,179,800 | Feb 03, 2022, 05:56 PM |
ZACCARDELLI DAVID | President and CEO | Feb 01, 2022 | Option Exercise | $0.78 | 288,648 | 224,077 | 16,891,152 | Feb 03, 2022, 05:56 PM |
ZACCARDELLI DAVID | President and CEO | Feb 03, 2022 | Sale | $0.73 | 52,056 | 37,772 | 16,839,096 | Feb 03, 2022, 05:56 PM |
Poll Claire | General Counsel | Feb 01, 2022 | Option Exercise | $0.78 | 79,896 | 62,023 | 1,922,847 | Feb 03, 2022, 05:55 PM |
Hahn Mark W | Chief Financial Officer | Feb 01, 2022 | Option Exercise | $0.75 | 133,776 | 99,998 | 16,124,896 | Feb 03, 2022, 05:54 PM |
Hahn Mark W | Chief Financial Officer | Feb 01, 2022 | Option Exercise | $0.78 | 288,320 | 223,794 | 15,836,576 | Feb 03, 2022, 05:54 PM |
Hahn Mark W | Chief Financial Officer | Feb 02, 2022 | Sale | $0.76 | 10,416 | 7,877 | 15,826,160 | Feb 03, 2022, 05:54 PM |
Deschamps Lisa | Director | Nov 02, 2021 | Sale | $0.66 | 11,672 | 7,690 | 81,984 | Nov 03, 2021, 07:53 PM |
Rickard Kathleen A. | Chief Medical Officer | Nov 01, 2021 | Option Exercise | $0.64 | 56,928 | 36,434 | 2,782,488 | Nov 03, 2021, 07:53 PM |
ZACCARDELLI DAVID | President and CEO | Nov 01, 2021 | Option Exercise | $0.64 | 454,848 | 291,103 | 16,897,408 | Nov 03, 2021, 07:52 PM |
ZACCARDELLI DAVID | President and CEO | Nov 02, 2021 | Sale | $0.64 | 52,056 | 33,373 | 16,845,352 | Nov 03, 2021, 07:52 PM |
Poll Claire | General Counsel | Nov 01, 2021 | Option Exercise | $0.64 | 79,896 | 51,133 | 2,002,743 | Nov 03, 2021, 07:51 PM |
Hahn Mark W | Chief Financial Officer | Nov 01, 2021 | Option Exercise | $0.64 | 454,848 | 291,103 | 16,001,536 | Nov 03, 2021, 07:51 PM |
Hahn Mark W | Chief Financial Officer | Nov 02, 2021 | Sale | $0.65 | 10,416 | 6,721 | 15,991,120 | Nov 03, 2021, 07:51 PM |
ZACCARDELLI DAVID | President and CEO | Aug 03, 2021 | Sale | $0.75 | 17,656 | 13,284 | 17,352,256 | Aug 09, 2021, 08:58 PM |
ZACCARDELLI DAVID | President and CEO | Aug 01, 2021 | Option Exercise | $0.79 | 454,848 | 357,056 | 17,404,312 | Aug 04, 2021, 08:12 PM |
ZACCARDELLI DAVID | President and CEO | Aug 04, 2021 | Sale | $0.74 | 18,400 | 13,675 | 17,369,912 | Aug 04, 2021, 08:12 PM |
ZACCARDELLI DAVID | President and CEO | Aug 03, 2021 | Sale | $0.76 | 16,000 | 12,210 | 17,388,312 | Aug 04, 2021, 08:12 PM |
Deschamps Lisa | Director | Aug 01, 2021 | Option Exercise | $0.79 | 11,664 | 9,156 | 93,656 | Aug 04, 2021, 07:41 PM |
Rickard Kathleen A. | Chief Medical Officer | Aug 01, 2021 | Option Exercise | $0.79 | 227,736 | 178,773 | 2,839,416 | Aug 03, 2021, 10:00 PM |
Poll Claire | General Counsel | Aug 01, 2021 | Option Exercise | $0.79 | 319,600 | 250,886 | 2,443,039 | Aug 03, 2021, 09:59 PM |
Hahn Mark W | Chief Financial Officer | Aug 01, 2021 | Option Exercise | $0.79 | 454,840 | 357,049 | 16,466,800 | Aug 03, 2021, 09:45 PM |
Hahn Mark W | Chief Financial Officer | Aug 02, 2021 | Sale | $0.77 | 10,416 | 7,989 | 16,456,384 | Aug 03, 2021, 09:45 PM |
Cunningham Kenneth | Director | May 04, 2021 | Sale | $0.84 | 13,112 | 11,010 | 66,584 | May 05, 2021, 05:06 PM |
Sinha Vikas | Director | May 04, 2021 | Sale | $0.84 | 10,016 | 8,410 | 74,440 | May 05, 2021, 05:05 PM |
EBSWORTH DAVID R | Director | May 04, 2021 | Sale | $0.84 | 11,184 | 9,391 | 684,643 | May 05, 2021, 05:04 PM |
Edwards Martin | Director | May 04, 2021 | Sale | $0.84 | 12,024 | 10,097 | 111,064 | May 05, 2021, 05:04 PM |
ZACCARDELLI DAVID | President and CEO | May 03, 2021 | Option Exercise | $0.89 | 2,139,632 | 1,898,923 | 17,911,216 | May 05, 2021, 04:06 PM |
ZACCARDELLI DAVID | President and CEO | May 04, 2021 | Sale | $0.81 | 52,056 | 41,926 | 17,859,160 | May 05, 2021, 04:06 PM |
Hahn Mark W | Chief Financial Officer | Mar 01, 2021 | Sale | $1.14 | 26,728 | 30,571 | 19,054,504 | Mar 03, 2021, 08:05 PM |
ZACCARDELLI DAVID | President and CEO | Mar 01, 2021 | Sale | $1.14 | 43,392 | 49,627 | 20,050,848 | Mar 03, 2021, 08:03 PM |
Ullman Anders | Director | Feb 01, 2021 | Sale | $0.99 | 10,800 | 10,733 | 346,912 | Feb 03, 2021, 07:11 PM |
Sinha Vikas | Director | Feb 01, 2021 | Sale | $0.99 | 10,224 | 10,161 | 84,456 | Feb 03, 2021, 07:11 PM |
SHAH MAHENDRA | Director | Feb 01, 2021 | Sale | $0.99 | 10,800 | 10,733 | 83,760 | Feb 03, 2021, 07:10 PM |
Edwards Martin | Director | Feb 01, 2021 | Sale | $0.99 | 13,688 | 13,603 | 123,088 | Feb 03, 2021, 07:09 PM |
EBSWORTH DAVID R | Director | Feb 01, 2021 | Sale | $0.99 | 11,912 | 11,838 | 695,827 | Feb 03, 2021, 07:09 PM |
Cunningham Kenneth | Director | Feb 01, 2021 | Sale | $0.99 | 13,104 | 13,023 | 79,696 | Feb 03, 2021, 07:08 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Owner | Relationship | Date | Value($) |
ZACCARDELLI DAVID | President and CEO | 02/01/2024 | 1,101,483 |
Rickard Kathleen A. | Chief Medical Officer | 02/01/2024 | 166,915 |
Rickard Kathleen A. | Chief Medical Officer | 02/05/2024 | 80,503 |
Poll Claire | General Counsel | 02/01/2024 | 237,197 |
Hahn Mark W | Chief Financial Officer | 02/01/2024 | 1,102,547 |
Edwards Martin | Director | 11/20/2023 | 61,973 |
EBSWORTH DAVID R | Director | 11/06/2023 | 316,080 |
Rickard Kathleen A. | Chief Medical Officer | 11/01/2023 | 301,915 |
Rickard Kathleen A. | Chief Medical Officer | 11/03/2023 | 112,804 |
Poll Claire | General Counsel | 11/01/2023 | 303,254 |
ZACCARDELLI DAVID | President and CEO | 11/01/2023 | 1,410,748 |
Hahn Mark W | Chief Financial Officer | 11/01/2023 | 1,410,748 |
Rickard Kathleen A. | Chief Medical Officer | 08/04/2023 | 69,838 |
Rickard Kathleen A. | Chief Medical Officer | 08/03/2023 | 128,790 |
Rickard Kathleen A. | Chief Medical Officer | 08/07/2023 | 3,949 |
ZACCARDELLI DAVID | President and CEO | 08/07/2023 | 21,263 |
ZACCARDELLI DAVID | President and CEO | 08/04/2023 | 374,880 |
ZACCARDELLI DAVID | President and CEO | 08/03/2023 | 297,754 |
Hahn Mark W | Chief Financial Officer | 08/04/2023 | 374,880 |
Hahn Mark W | Chief Financial Officer | 08/03/2023 | 297,754 |
Hahn Mark W | Chief Financial Officer | 08/07/2023 | 21,263 |
Poll Claire | General Counsel | 08/07/2023 | 3,731 |
Poll Claire | General Counsel | 08/04/2023 | 65,859 |
Poll Claire | General Counsel | 08/03/2023 | 52,324 |
Hahn Mark W | Chief Financial Officer | 08/01/2023 | 283,824 |
Hahn Mark W | Chief Financial Officer | 08/02/2023 | 191,114 |
Poll Claire | General Counsel | 08/02/2023 | 33,564 |
Poll Claire | General Counsel | 08/01/2023 | 49,851 |
ZACCARDELLI DAVID | President and CEO | 08/02/2023 | 191,114 |
ZACCARDELLI DAVID | President and CEO | 08/01/2023 | 283,824 |
Rickard Kathleen A. | Chief Medical Officer | 08/02/2023 | 35,597 |
Rickard Kathleen A. | Chief Medical Officer | 08/01/2023 | 52,873 |
ORBIMED ADVISORS LLC | Director | 05/15/2023 | 7,222,484 |
ORBIMED ADVISORS LLC | Director | 05/12/2023 | 934,848 |
ORBIMED ADVISORS LLC | Director | 05/11/2023 | 1,780,800 |
Gupta Rishi | Director | 05/15/2023 | 7,222,484 |
Gupta Rishi | Director | 05/12/2023 | 934,848 |
Gupta Rishi | Director | 05/11/2023 | 1,780,800 |
Poll Claire | General Counsel | 05/01/2023 | 207,041 |
Rickard Kathleen A. | Chief Medical Officer | 05/03/2023 | 76,242 |
Rickard Kathleen A. | Chief Medical Officer | 05/01/2023 | 199,436 |
Hahn Mark W | Chief Financial Officer | 05/01/2023 | 1,173,395 |
ZACCARDELLI DAVID | President and CEO | 05/01/2023 | 1,173,415 |
Hahn Mark W | Chief Financial Officer | 02/01/2023 | 1,056,553 |
ZACCARDELLI DAVID | President and CEO | 02/01/2023 | 1,107,083 |
Rickard Kathleen A. | Chief Medical Officer | 02/02/2023 | 72,685 |
Rickard Kathleen A. | Chief Medical Officer | 02/01/2023 | 230,046 |
Poll Claire | General Counsel | 02/01/2023 | 394,273 |
Poll Claire | General Counsel | 12/22/2022 | 646,032 |
ORBIMED ADVISORS LLC | Director | 12/23/2022 | 49,576,607 |
ORBIMED ADVISORS LLC | Director | 12/22/2022 | 86,424,246 |
Gupta Rishi | Director | 12/23/2022 | 49,576,607 |
Gupta Rishi | Director | 12/22/2022 | 86,424,246 |
ZACCARDELLI DAVID | President and CEO | 12/20/2022 | 1,269,600 |
Hahn Mark W | Chief Financial Officer | 12/20/2022 | 1,269,060 |
ZACCARDELLI DAVID | President and CEO | 11/01/2022 | 727,770 |
ZACCARDELLI DAVID | President and CEO | 11/01/2022 | 55,035 |
Rickard Kathleen A. | Chief Medical Officer | 11/01/2022 | 90,022 |
Rickard Kathleen A. | Chief Medical Officer | 11/01/2022 | 47,125 |
Hahn Mark W | Chief Financial Officer | 11/01/2022 | 727,770 |
Hahn Mark W | Chief Financial Officer | 11/01/2022 | 22,011 |
Access Industries Holdings LLC | 10% Owner | 08/15/2022 | 6,300,000 |
ZACCARDELLI DAVID | President and CEO | 08/09/2022 | 1,050,000 |
Hahn Mark W | Chief Financial Officer | 08/09/2022 | 1,050,000 |
ZACCARDELLI DAVID | President and CEO | 08/01/2022 | 305,896 |
ZACCARDELLI DAVID | President and CEO | 08/01/2022 | 23,026 |
Rickard Kathleen A. | Chief Medical Officer | 08/01/2022 | 37,951 |
Rickard Kathleen A. | Chief Medical Officer | 08/02/2022 | 20,216 |
Hahn Mark W | Chief Financial Officer | 08/01/2022 | 305,891 |
Hahn Mark W | Chief Financial Officer | 08/01/2022 | 9,215 |
Poll Claire | General Counsel | 08/01/2022 | 53,730 |
ZACCARDELLI DAVID | President and CEO | 05/03/2022 | 16,307 |
Rickard Kathleen A. | Chief Medical Officer | 05/03/2022 | 14,155 |
Hahn Mark W | Chief Financial Officer | 05/03/2022 | 6,201 |
Rickard Kathleen A. | Chief Medical Officer | 05/01/2022 | 29,486 |
Poll Claire | General Counsel | 05/01/2022 | 41,746 |
Hahn Mark W | Chief Financial Officer | 05/01/2022 | 225,787 |
ZACCARDELLI DAVID | President and CEO | 05/01/2022 | 237,666 |
Rickard Kathleen A. | Chief Medical Officer | 04/11/2022 | 32,100 |
Rickard Kathleen A. | Chief Medical Officer | 04/08/2022 | 66,383 |
Deschamps Lisa | Director | 02/01/2022 | 9,069 |
Rickard Kathleen A. | Chief Medical Officer | 02/01/2022 | 49,335 |
ZACCARDELLI DAVID | President and CEO | 02/01/2022 | 250,000 |
ZACCARDELLI DAVID | President and CEO | 02/01/2022 | 224,077 |
ZACCARDELLI DAVID | President and CEO | 02/03/2022 | 37,772 |
Poll Claire | General Counsel | 02/01/2022 | 62,023 |
Hahn Mark W | Chief Financial Officer | 02/01/2022 | 99,998 |
Hahn Mark W | Chief Financial Officer | 02/01/2022 | 223,794 |
Hahn Mark W | Chief Financial Officer | 02/02/2022 | 7,877 |
Deschamps Lisa | Director | 11/02/2021 | 7,690 |
Rickard Kathleen A. | Chief Medical Officer | 11/01/2021 | 36,434 |
ZACCARDELLI DAVID | President and CEO | 11/01/2021 | 291,103 |
ZACCARDELLI DAVID | President and CEO | 11/02/2021 | 33,373 |
Poll Claire | General Counsel | 11/01/2021 | 51,133 |
Hahn Mark W | Chief Financial Officer | 11/01/2021 | 291,103 |
Hahn Mark W | Chief Financial Officer | 11/02/2021 | 6,721 |
ZACCARDELLI DAVID | President and CEO | 08/03/2021 | 13,284 |
ZACCARDELLI DAVID | President and CEO | 08/01/2021 | 357,056 |
ZACCARDELLI DAVID | President and CEO | 08/04/2021 | 13,675 |
ZACCARDELLI DAVID | President and CEO | 08/03/2021 | 12,210 |
Deschamps Lisa | Director | 08/01/2021 | 9,156 |
Rickard Kathleen A. | Chief Medical Officer | 08/01/2021 | 178,773 |
Poll Claire | General Counsel | 08/01/2021 | 250,886 |
Hahn Mark W | Chief Financial Officer | 08/01/2021 | 357,049 |
Hahn Mark W | Chief Financial Officer | 08/02/2021 | 7,989 |
Cunningham Kenneth | Director | 05/04/2021 | 11,010 |
Sinha Vikas | Director | 05/04/2021 | 8,410 |
EBSWORTH DAVID R | Director | 05/04/2021 | 9,391 |
Edwards Martin | Director | 05/04/2021 | 10,097 |
ZACCARDELLI DAVID | President and CEO | 05/03/2021 | 1,898,923 |
ZACCARDELLI DAVID | President and CEO | 05/04/2021 | 41,926 |
Hahn Mark W | Chief Financial Officer | 03/01/2021 | 30,571 |
ZACCARDELLI DAVID | President and CEO | 03/01/2021 | 49,627 |
Ullman Anders | Director | 02/01/2021 | 10,733 |
Sinha Vikas | Director | 02/01/2021 | 10,161 |
SHAH MAHENDRA | Director | 02/01/2021 | 10,733 |
Edwards Martin | Director | 02/01/2021 | 13,603 |
EBSWORTH DAVID R | Director | 02/01/2021 | 11,838 |
Cunningham Kenneth | Director | 02/01/2021 | 13,023 |
Load More Insider Transactions
FUNDS WITH A POSITION IN VERONA PHARMA PLC
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
RA CAPITAL MANAGEMENT, L.P. | 6,317,990 | 1.96% | No change | Other |
VIVO CAPITAL, LLC | 3,610,177 | 4.56% | -15.05% | Other |
ORBIMED ADVISORS LLC | 3,777,778 | 1.5% | No change | Other |
MAVERICK CAPITAL LTD | 1,656,492 | 0.66% | New | Growth At A Reasonable Price, Growth |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 651,931 | 0.03% | 52.7% | Other |
BLACKROCK INC. | 364,613 | 0.00018% | 8.58% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 61,113 | 0.00013% | 16.43% | Other |
ALPS ADVISORS INC | 54,048 | 0.00845% | -7.79% | Other |
UBS OCONNOR LLC | 48,533 | 0.07% | -44.61% | Value |
CHANGE IN SHARES OUTSTANDING FOR VERONA PHARMA PLC
STOCK BUYBACKS FOR VERONA PHARMA PLC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
0.62%
1Q
06/30/2023
1.22%
2Q
03/31/2023
3.34%
3Q
09/30/2022
18.03%
5Q
06/30/2022
32.48%
6Q
03/31/2022
33.26%
7Q
09/30/2021
24.51%
9Q
06/30/2021
36.42%
10Q
03/31/2021
36.80%
11Q
09/30/2020
86.26%
13Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR VERONA PHARMA PLC
LOADING...